An edition of Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents (2002)

Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.

by

Comparative clinical and budget evaluations o ...
Canadian Coordinating Office f ...
Locate

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today
Notes
Notes

Check nearby libraries

Buy this book

Last edited by MARC Bot
July 31, 2019 | History
Edit
An edition of Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents (2002)

Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.

by

This edition doesn't have a description yet. Can you add one?

Publish Date
Publisher
Canadian Coordinating Office for Health Technology Assessment
Language
English
Pages
17

Check nearby libraries

Buy this book

Subjects

Chemotherapy, Hypoglycemic agents, Diabetes, Cost-Benefit Analysis, Cost effectiveness, Drug therapy, Diabetes Mellitus, Therapeutic use, Hypoglycemic Agents
Edition Availability
Cover of: Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.
Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents.
2003, Canadian Coordinating Office for Health Technology Assessment
in English
Cover of: Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents
Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis
2002, Canadian Coordinating Office for Health Technology Assessment
in English
Cover of: Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents
Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis
2002, Canadian Coordinating Office for Health Technology Assessment
in English

Add another edition?

Book Details

Edition Notes

Based on Technology report, no. 29, entitled: Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents : systematic review and budget impact analysis.

"April 2003."

Includes bibliographical references.

Published in
Ottawa
Series
Technology overview -- issue 9, Technology overview (Ottawa, Ont. : 1998) -- issue 9.
Other Titles
Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents.

The Physical Object

Pagination
iv, 17 p. :
Number of pages
17

ID Numbers

Open Library
OL21487691M
ISBN 10
1894620577

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON / OPDS | Wikipedia citation
July 31, 2019 Edited by MARC Bot associate edition with work OL19045458W
November 2, 2008 Created by ImportBot Imported from University of Toronto MARC record